Cefoxive 750 mg Combipack Injection 1's

Cefoxive 750 mg Combipack Injection 1's belongs to the class of cephalosporin antibiotics indicated to treat a wide range of bacterial infections including lower respiratory tract infections, urinary tract infections, skin and skin structure infections, septicemia (blood infection), meningitis (infection of brain and spinal cord), gonorrhoea (sexually transmitted infections), bone and joint infections. Cefoxive 750 mg Combipack Injection 1's is also used to prevent infections during surgery. 

Cefoxive 750 mg Combipack Injection 1's is a broad-spectrum antibiotic that acts against a wide range of bacteria. It works by blocking the activity of an enzyme that makes peptidoglycan (a vital component of the bacterial cell wall). This prevents the formation of bacterial cell covering, thereby kills the bacteria and treats bacterial infection.

A healthcare expert will administer Cefoxive 750 mg Combipack Injection 1's; do not self-administer. In some cases, Cefoxive 750 mg Combipack Injection 1's may cause side effects such as diarrhoea, nausea, vomiting, pain, and swelling at the site of injection. Most of these side effects do not require medical attention and resolve over time. However, if the side effects persist or worsen, consult your doctor.

Let your doctor know about your medical condition and the medications you are taking to avoid the occurrence of potential interactions. Consult your doctor if you are pregnant, breastfeeding, suspect you are pregnant or plan to have a baby; your doctor will weigh the benefits of Cefoxive 750 mg Combipack Injection 1's therapy against the risk to your baby. Cefoxive 750 mg Combipack Injection 1's may cause dizziness, so drive only if you are alert.

Cefoxive 750 mg Combipack Injection 1's is used to treat respiratory tract infections, ear infections, skin infections, genitourinary infections, and bone infections. Besides this, Cefoxive 750 mg Combipack Injection 1's is also used to prevent infection after surgery and in the early treatment of Lyme disease caused by bacteria (Borrelia burgdorferi) in adults and children over the age of 12 years. Cefoxive 750 mg Combipack Injection 1's is a broad-spectrum antibiotic that acts against a wide range of bacteria. It works by blocking the activity of an enzyme that makes peptidoglycan (a vital component of the bacterial cell wall). This prevents the formation of bacterial cell covering, thereby kills the bacteria and treats bacterial infection.

• Pain and swelling at the site of injection
• Diarrhoea
• Nausea
• Vomiting

Do not take Cefoxive 750 mg Combipack Injection 1's if you are allergic to any of the contents. Consult your doctor if you are pregnant or breastfeeding. Inform your doctor if you have kidney or liver problems. Cefoxive 750 mg Combipack Injection 1's may cause Clostridioides difficile-associated diarrhoea (CDAD). If you experience a severe, persistent diarrhoea, or if you find blood or mucus in stools, consult your doctor immediately. Let your doctor know about your medical condition and the medications you are taking to avoid the occurrence of potential interactions.

• After completing the course of Cefoxive 750 mg Combipack Injection 1's, probiotics should be taken to restore healthy bacteria in the intestine that may have been killed. Taking probiotics after antibiotic treatment can reduce the risk of antibiotic-associated diarrhoea. Certain fermented foods like yoghurt, cheese, sauerkraut, and kimchi can help restore the intestine's good bacteria.
• Include more fibre-enriched food in your diet, as it can be easily digested by gut bacteria which helps stimulate their growth. 
• Avoid taking too much calcium enriched foods and drinks as it might affect the working of Cefoxive 750 mg Combipack Injection 1's.
• Avoid intake of alcoholic beverages with Cefoxive 750 mg Combipack Injection 1's as it can make you dehydrated and affect your sleep. This can make it harder for your body to aid Cefoxive 750 mg Combipack Injection 1's in fighting off infections.